Changing the gut microbiome can reprogram the immune system to attack malignant tumors, according to results of a unique clinical trial at Sheba Medical Center in Israel.
The results were published in the peer-reviewed journal Science by a research team led by senior GI oncologist Dr. Ben Boursi, senior oncologist Dr. Gal Markel and MD-PhD student Erez Baruch.
“For the first time in the world, we have successfully fought cancerous tumors by changing the gut microbiome,” Boursi said.